...
首页> 外文期刊>Journal of Pharmacopuncture >Pharmacopuncture of Bauhinia variegata Nanoemulsion Formulation against Diabetic Peripheral Neuropathic Pain
【24h】

Pharmacopuncture of Bauhinia variegata Nanoemulsion Formulation against Diabetic Peripheral Neuropathic Pain

机译:Bauhinia Variegata纳米乳剂配方对糖尿病外周神经治疗的药物潜水

获取原文

摘要

Objectives: The objective of the study was to prepare Bauhinia variegata loaded nanoemulsion(formulation and determine the efficacy of herbal drug formulation against diabetic peripheral neuropathic pain through acupuncture technique. Methods: Nine different ba tches of nanoemulsion (NE1 NE9) of BVN was prepared by varying the Smix ratio and the concentration of oil. BVN was characterized to determine particle size, shape, zeta potential, polydispersity index, optical transmittance, drug release profile and stora ge stability. The optimized formulation was subjected to plantar test, behavioral tests of neuropathic pain and Von Frey filament stimulation test. Diabetes was induced by intraperitoneal injection of freshly prepared solution of Streptozotocin (60 mg/kg) to the experimental rats. Animals were made diabetic divided into four groups, Group I was untreated normal control group, Group II was diabetic control group, Group III was Bauhinia variegata extract ( treated group (100 mg/kg/day, p.o) and Group IV was BVN treated groups (100 mg/kg/day, p.o) acute and chronically. Results: The prepared B. variegata loaded nanoemulsion was nanosized (124 nm), spherical, uniform and stable over the period of 180 days with no change in physiochemical properties. The bl ood glucose and body weight of animals was normalizing after four weeks of treatment that was significant with BVN in comparison to diabetic control group. The chronic administration of BVN significantly (P0.001) decreased hind paw withdrawal latency an d attenuated mechanical allodynia as compared with diabetic rats. Conclusion: Thus, BVN may be an effective drug formulation against diabetic peripheral neuropathic pain.
机译:目的:该研究的目的是准备紫荆瓦葡萄球菌负载纳米乳剂(制剂,通过针灸技术通过针对糖尿病外周神经性疼痛确定草药药物制剂的疗效。方法:BVN的九种不同BA TCHE的BVN纳米乳液(NE1 NE9)改变SMIX的比例和油的浓度。BVN的特征在于确定粒度,形状,Zeta电位,多分散性指数,光学透射率,药物释放曲线和斯库塔Ge稳定性。对Purerar试验进行优化的制剂,神经性的行为试验疼痛和von frey长丝刺激测试。通过腹膜内注射新制备的链脲佐菌素(60mg / kg)溶液诱导糖尿病,对实验大鼠进行糖尿病。将糖尿病患者分为四组,群体是未处理的正常对照组,II组是糖尿病对照组,III组是紫荆瓦葡萄球菌提取物(治疗组(100毫克/ kg / day,p.o)和第四组是Bvn处理基团(100mg / kg /天,p.o)急性和长期。结果:制备的B.Variegata负载纳米乳液是纳米级(124nm),球形,均匀,在180天的时间内稳定,物理化学性质没有变化。与糖尿病对照组相比,与BVN有显着的治疗后,动物的BL OOD葡萄糖和体重是正常化的。与糖尿病大鼠相比,BVN的慢性施用显着(P <0.001)降低了D减弱的机械异常性疼痛。结论:因此,BVN可以是针对糖尿病外周神经性疼痛的有效药物制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号